Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Biemans
Augustines Gerardus Maria Biemans, Geldrop NL
| Patent application number | Description | Published |
|---|---|---|
| 20090194911 | OPTICAL MICRO-ARRAY FOR E.G. MICRO SENSORS - Method for manufacturing a polymer body ( | 08-06-2009 |
| 20100025870 | METHOD AND APPARATUS FOR MANUFACTURING A POLYMERIC ARTICLE - The invention is directed to a method for manufacturing, in one production step and from one material, a polymeric article having at least one optical transparent area and at least one optical non-transparent area. The inventors found that it is possible to simultaneously create transparent and non-transparent areas, while the article is formed, by influencing specific cooling parameters. | 02-04-2010 |
Michael Dennis Biemans, Eindhoven NL
| Patent application number | Description | Published |
|---|---|---|
| 20100218206 | VIEWER PRESENCE DETECTION - One embodiment of the present invention sets forth a method for determining a chance that a user is present at a current time while a client device is tuned to a channel by monitoring a user input to the client device and determining a time when the user provides the user input. At the time when the user provides the user input, the chance is assigned an initial value. After that, the chance varies over time according to a first function. The chance that the user is present at the current time is then determined using the initial value and the first function. As a result, a chance of a user being present while a client device plays out media segments may be determined without incurring the costs of providing additional hardware and without requiring the user to register and unregister. | 08-26-2010 |
Ralph Biemans, Rixensart BE
| Patent application number | Description | Published |
|---|---|---|
| 20100291137 | METHOD FOR REFOLDING NEISSERIAL NSPA PROTEIN - The present invention provides an isolated refolded NspA protein, and a method of preparing it. | 11-18-2010 |
| 20110033500 | VACCINE COMPOSITIONS COMPRISING L2 AND/OR L3 IMMUNOTYPE LIPOOLIGOSACCHARIDES FROM LGTB-NEISSERIA MENINGITIDIS - The present invention relates to the field of neisserial vaccine compositions, their manufacture, and the use of such compositions in medicine. More particularly it relates to processes of making novel engineered meningococcal strains which are more suitable for the production of neisserial, in particular meningococcal, outer-membrane vesicle (or bleb) vaccines. Advantageous processes and vaccine products are also described based on the use of novel LOS subunit or meningococcal outer-membrane vesicle (or bleb) vaccines which have been rendered safer and/or more effective for use in human subjects. In particular combinations of gene downregulations are described such as PorA and OpA, PorA and OpC, OpA and OpC, and PorA and OpA and OpC. Alternatively, or in addition, lgtB | 02-10-2011 |
Rogier Biemans, Boxmeer NL
| Patent application number | Description | Published |
|---|---|---|
| 20100260795 | Carrier Particle for a Microorganism or Subunit Thereof, Pharmaceutical Composition Comprising such Particles, Method for Preparation of this Composition and Its Use in the Treatment of Animals - The invention pertains to a carrier particle comprising a hydrophilic phase containing a micro-organism and/or subunit thereof, the hydrophilic phase being dispersed in a hydrophobic continuous phase being solid at room temperature, wherein the hydrophobic phase is constituted to undergo a solid-to-liquid conversion at a temperature above room temperature, the conversion comprising a first order transition. The invention also pertains to a pharmaceutical composition comprising said particles, a method for preparation the pharmaceutical composition and the use of this composition in the treatment of an animal. | 10-14-2010 |